A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2006
10/18/2006	CN1279938C Chinese patented medicine for treating nephritis
10/18/2006	CN1279936C Medicine for treating coronary heart disease and angina pectoris and restenosis after intervention operation
10/18/2006	CN1279926C Medicine for treating burns and scalds and its preparation method
10/18/2006	CN1279925C Capsules of complete active substances of pilose antler and their preparation
10/18/2006	CN1279923C Human body lubricant of containing fucose and hyaluronic acid, and its prepn. method
10/18/2006	CN1279922C Paeonal injection emulsion for anti-tumor and its preparing method
10/18/2006	CN1279921C Extraction method of Anhui fritillary extract
10/18/2006	CN1279920C Slow release preparation of diammonium glycyrrhizate
10/18/2006	CN1279919C Pharmaceutical compositions containing ginsenoside, safflor yellow and its preparation and application
10/18/2006	CN1279918C Energy-supplementing saccharide source and its uses
10/18/2006	CN1279917C Vulnerary, its preparation method and process of using
10/18/2006	CN1279916C 3,7-diazybicyclo [3.3.1] for mulations as antiarrhytmic compounds
10/18/2006	CN1279915C Use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno(2, 3-D)-pyrimidine for treating of urinary incontinence
10/18/2006	CN1279914C Minoxidil-containing preparations
10/18/2006	CN1279913C Compound preparation containing rifampicin and isoniazid and its preparing method
10/18/2006	CN1279912C Use of sinomenine
10/18/2006	CN1279911C Method of treating benign prostatic hyperplasia and other benign prostate conditions
10/18/2006	CN1279910C Milianone freeze dried preparation
10/18/2006	CN1279909C Freeze dried combination of Lansoprazole available for linjection and preparation method
10/18/2006	CN1279908C Amlexanox double layer oral patches and its preparing method
10/18/2006	CN1279907C Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy
10/18/2006	CN1279906C Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof
10/18/2006	CN1279905C Enteric migelinai agent and its preparation method
10/18/2006	CN1279904C Vitamin C composition containing sodium vitamin C
10/18/2006	CN1279903C Preparation containing Gingkolactone and its producing process
10/18/2006	CN1279902C Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
10/18/2006	CN1279901C Pharmaceutical composition for the treatment of seborrhea containing 4-hydroxy-5-methoxy-4-[2-methyl-3(3-methyl-2-butenyl)-2-oxiranyl]-1-oxaspiro[2,5]octan-6-one
10/18/2006	CN1279900C Gabapentin analogues for sleep disorders
10/18/2006	CN1279899C Process for producing granules containing branched amino acids
10/18/2006	CN1279898C Application of glycine in preparing medicine
10/18/2006	CN1279897C Freeze dry preparation containing diclofenac salt and lidocaine and its preparation method
10/18/2006	CN1279896C Tramadol hydrochloride oral disintegration tablets, and prepn. method therefor
10/18/2006	CN1279893C Surfactant compounds and uses thereof
10/18/2006	CN1279892C Fat emulsion injection of 'Xingnaojing' and its preparing process
10/18/2006	CN1279891C Use of water solution containing positive ion cellulose polymer in preparation of drug for treating dry eye
10/18/2006	CN1279844C Nutritional supplement to treat macular degeneration
10/18/2006	CN1279843C Dietary compositions and methods
10/18/2006	CA2503099A1 Pharmaceutical compositions containing camptothecins
10/17/2006	US7122687 Sodium salt formation of Mycophenolic acid
10/17/2006	US7122682 Chemical intermediates used for manufacturing (S)-(-)- alpha -ethyl-2-oxo-1-pyrrolidine acetamide which is used in therapy and prophylaxis epilepsy and other neurological disorders
10/17/2006	US7122681 Displacement of solvent by vapor diffusion of water
10/17/2006	US7122680 3-Substituted oxindole β3 agonsists
10/17/2006	US7122679 Multicyclic compounds and the use thereof
10/17/2006	US7122678 (Trans)-(3,4-Dimethyl-cyclopentyldine)-acetic acid ethyl ester; treating epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, irritable bowel syndrome (IBS), and inflammation
10/17/2006	US7122677 NK1 antagonists
10/17/2006	US7122675 Gamma secretase inhibitors
10/17/2006	US7122673 Cyclization of imines to form compounds such as 4-Phenyl-6H-(1)Benzopyrano(4',3':4,5)pyrrolo(2,1-a)isoquinolin-6-one, used as nontoxic modulators of multidrug resistant cells; antitumor agents
10/17/2006	US7122670 Adding a Lewis acid to the reaction medium selectively adds an amine functionality to the C-2 position of a CF3 substituted-pyrimidine ring; treating abnormal cell growth, cancer, in mammals
10/17/2006	US7122669 Purine derivatives, preparation method and pharmaceutical compositions containing same
10/17/2006	US7122668 Platinum complexes and their use in therapy
10/17/2006	US7122652 Isolated polynucleotide encoding a variant human pregnane X receptor (hPXR) polypeptide or fragment; detection and genotyping of hPXR alleles in humans, homozygous as well as heterozygous, alleles of the hPXR gene
10/17/2006	US7122643 Cytostatic lanthanum compounds
10/17/2006	US7122639 Chemokine alpha-2 antibodies
10/17/2006	US7122635 Method and composition for angiogenesis inhibition
10/17/2006	US7122618 Cosmetics, drugs, plant safening agents, microbiocides, textiles
10/17/2006	US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc
10/17/2006	US7122579 Eye treatments using synthetic thyroid hormone compositions
10/17/2006	US7122578 Method and composition for treating mammalian diseases and injuries which cause pain, erythema, swelling, crusting, ischemia scarring and excess white blood cell infiltration
10/17/2006	US7122577 Use of mycolic acids possessing immunoregulatory and immunogenic properties in the prophylaxis and/or therapy of diseases, particularly those induced by or associated with Mycobacteria
10/17/2006	US7122576 Carbamate compounds for use in preventing or treating bipolar disorder
10/17/2006	US7122574 Procyanidins as antineoplastic agents; topolisomerase, cylooxygenase, and/or lipoxygenase inhibitors; nitric oxide synthase modulators; hypotensive agents
10/17/2006	US7122573 A flavonoids, anticarcinogenic agents for treating cancer, such as catechin, epigallocatichin-3-gallate
10/17/2006	US7122572 For use in Hydrogen Bonding Liquid Chromatography, environmental remediation by removal of undesired ions or neutral molecules, removal of phosphate for kidney dialysis, drug delivery, separation
10/17/2006	US7122571 Substituted hydrazones as inhibitors of cyclooxygenase-2
10/17/2006	US7122570 Tetrahydrocarbazol derivatives as ligands for G-protein-coupled receptors (GPCR)
10/17/2006	US7122569 Treatment of tumors by irradiating with light after administration of protoporphyrin derivative; ethylene glycol esters of monohydrobenzoporphyrins
10/17/2006	US7122568 Use of low-dose PDT to inhibit restenosis
10/17/2006	US7122567 Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity
10/17/2006	US7122566 Informing patient or a medical care worker that metaxalone affects activity of a cytochrome p450 isozyme, and that administration of metaxalone with a substance that affects activity of a cytochrome p450 isozyme can affect plasma concentration, safety, efficacy of metaxalone, the substance, or both
10/17/2006	US7122565 Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors
10/17/2006	US7122563 Derivatives of 4-demethylpenclomedine, use thereof and preparation thereof
10/17/2006	US7122562 Amine oxidase inhibitor; use in treatment of Alzheimer's disease and senile dementia
10/17/2006	US7122561 Treatment of skin conditions
10/17/2006	US7122560 Lactam derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme
10/17/2006	US7122559 Useful as anticoagulants in therapy and prophylaxis of cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in therapy of cancer
10/17/2006	US7122558 Anticholinergic agents; chronic obstructive pulmonary diseases; incontinence; gastrointestinal disorders; antiulcer agents; cardiovascular disorders
10/17/2006	US7122557 5-chloro-N-(5-chloropyridin-2-yl)-2-[(4-{(Z)-(dimethylamino)[(methylsulfonyl)imino]methyl}benzoyl)amino]benzamide; treating thromboembolic disorders, optionally with other active agents
10/17/2006	US7122556 Phenylalanine enamide derivatives
10/17/2006	US7122555 Pyrido [2,1-a] isoquinoline derivatives
10/17/2006	US7122554 Sexual disorders therapy; hypotensive agents; chronic obstructive pulmonary disease; congestive heart failure; asthma; antiallergens
10/17/2006	US7122553 Liposomal formulation of irinotecan
10/17/2006	US7122552 Antiallergens; autoimmune diseases; antiproliferative agents; controlling signal transduction
10/17/2006	US7122551 Metalloproteinase inhibitor compounds
10/17/2006	US7122550 Protein kinase inhibitors
10/17/2006	US7122549 For therapy of cancer
10/17/2006	US7122548 Triazolotriazine compounds and uses thereof
10/17/2006	US7122547 Anthranilic acid amides and the use thereof as medicaments
10/17/2006	US7122546 GABAA (gamma-aminobutyric acid) receptor modulators; anxiolytic, antidepresant agents; attention deficit disorder, Alzheimer*s disease treatment; central nervous systmem disorders
10/17/2006	US7122545 Imidazo-benzothiazoles
10/17/2006	US7122544 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
10/17/2006	US7122543 Substituted benzoic acid derivatives having NF-κB inhibiting action
10/17/2006	US7122542 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
10/17/2006	US7122541 LIVER CANCER; ADMINISTERING TAUROLIDINE, direct contact a liver tissue by perfusion in situ, to increase caspase activity in a cell
10/17/2006	US7122540 2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
10/17/2006	US7122539 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications.
10/17/2006	US7122538 Neuroleptic agents for treating schizophrenia, psychological disorders, depression; 5-(4-Chlorophenyl)-thiophene-2-sulfonic acid (8-methoxy-3-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yl)amide
10/17/2006	US7122537 Which has superoxide acitivity, catalase activity, and/or peroxidase activity; for treating cell or tissue damage; improved organ, cell or tissue culture; diseases such as neurodegenerative diseases
10/17/2006	US7122536 (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity
10/17/2006	US7122535 For treating pain in a warm-blooded animal; enzyme inhibitor on NO-synthase enzymes; STROKE, NEURODEGENERATIVE DISEASES, ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS
10/17/2006	US7122534 Aryl fused azapolycyclic compounds

1 ... 4049 4050 4051 4052 4053 4054 4055 4056 4057 4058 4059 4060 4061 4062 4063 4064 4065 4066 4067 4068 4069 ... 7860